Esperion Therapeutics
ESPR
#6747
Rank
NZ$1.43 B
Marketcap
NZ$5.55
Share price
0.00%
Change (1 day)
34.60%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.41 Billion. In 2025 the company made an earning of NZ$0.11 Billion, an increase over its 2024 earnings that were of NZ$13.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B22.5%
2025 NZ$0.11 B749.49%
2024 NZ$13.1 M-104.99%
2023 -NZ$0.27 Billion-15.03%
2022 -NZ$0.31 Billion-20.61%
2021 -NZ$0.39 Billion84.28%
2020 -NZ$0.22 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.36 Billion19.57%
2017 -NZ$0.3 Billion125.39%
2016 -NZ$0.14 Billion51.43%
2015 -NZ$86.02 Million36.45%
2014 -NZ$63.04 Million43.55%
2013 -NZ$43.92 Million145.26%
2012 -NZ$17.91 Million
2002 -NZ$51.05 Million-7.81%
2001 -NZ$55.37 Million15.03%
2000 -NZ$48.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.49 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.00 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.94 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$45.56 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA